Article Details
Retrieved on: 2023-10-18 20:31:47
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
A new 2023-2024 formulation of the adjuvanted protein subunit COVID-19 vaccine manufactured by Novavax that was developed to more closely target ...
Article found on: secure.medicalletter.org
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here